Utilization of multiparametric prostate magnetic resonance imaging in clinical practice and focal therapy: report from a Delphi consensus project

[1]  M. Haider,et al.  Multiparametric Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer: A Systematic Review. , 2016, Clinical oncology (Royal College of Radiologists (Great Britain)).

[2]  P. Choyke,et al.  Prospective Evaluation of the Prostate Imaging Reporting and Data System Version 2 for Prostate Cancer Detection. , 2016, The Journal of urology.

[3]  C. Parker,et al.  The PROMIS study: A paired-cohort, blinded confirmatory study evaluating the accuracy of multi-parametric MRI and TRUS biopsy in men with an elevated PSA. , 2016 .

[4]  Katarzyna J Macura,et al.  Synopsis of the PI-RADS v2 Guidelines for Multiparametric Prostate Magnetic Resonance Imaging and Recommendations for Use. , 2016, European urology.

[5]  Antonio Garufi,et al.  Can MRI/TRUS fusion targeted biopsy replace saturation prostate biopsy in the re-evaluation of men in active surveillance? , 2016, World Journal of Urology.

[6]  J. Fütterer,et al.  Can Clinically Significant Prostate Cancer Be Detected with Multiparametric Magnetic Resonance Imaging? A Systematic Review of the Literature. , 2015, European urology.

[7]  Henry Rusinek,et al.  Image Guided Focal Therapy for Magnetic Resonance Imaging Visible Prostate Cancer: Defining a 3-Dimensional Treatment Margin Based on Magnetic Resonance Imaging Histology Co-Registration Analysis. , 2015, The Journal of urology.

[8]  Pierre Mozer,et al.  Detection of Clinically Significant Prostate Cancer Using Magnetic Resonance Imaging-Ultrasound Fusion Targeted Biopsy: A Systematic Review. , 2015, European urology.

[9]  P. Albers,et al.  The use of targeted MR-guided prostate biopsy reduces the risk of Gleason upgrading on radical prostatectomy , 2015, Journal of Cancer Research and Clinical Oncology.

[10]  H. Ahmed,et al.  Histological outcomes after focal high-intensity focused ultrasound and cryotherapy , 2015, World Journal of Urology.

[11]  Rajan T. Gupta,et al.  Current Trends and New Frontiers in Focal Therapy for Localized Prostate Cancer , 2015, Current Urology Reports.

[12]  J. Bernhard,et al.  Magnetic resonance imaging-transectal ultrasound image-fusion biopsies accurately characterize the index tumor: correlation with step-sectioned radical prostatectomy specimens in 135 patients. , 2015, European urology.

[13]  R. Saouaf,et al.  Impact of post prostate biopsy hemorrhage on multiparametric magnetic resonance imaging. , 2015, The Canadian journal of urology.

[14]  Ian A. Donaldson,et al.  Focal Therapy: Patients, Interventions, and Outcomes—A Report from a Consensus Meeting , 2015, European urology.

[15]  David Y. Lu,et al.  Multifocality and prostate cancer detection by multiparametric magnetic resonance imaging: correlation with whole-mount histopathology. , 2015, European urology.

[16]  G. Bratslavsky,et al.  Renal Cell Carcinoma in Young Patients: a Review of Recent Literature , 2015, Current Urology Reports.

[17]  G. Pond,et al.  A prospective comparison of MRI‐US fused targeted biopsy versus systematic ultrasound‐guided biopsy for detecting clinically significant prostate cancer in patients on active surveillance , 2015, Journal of magnetic resonance imaging : JMRI.

[18]  J. Fütterer,et al.  Follow-up modalities in focal therapy for prostate cancer: results from a Delphi consensus project , 2015, World Journal of Urology.

[19]  M. Stifelman,et al.  A prospective, blinded comparison of magnetic resonance (MR) imaging-ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy: the PROFUS trial. , 2014, European urology.

[20]  F. Schröder,et al.  Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies. , 2014, European urology.

[21]  Shyam Natarajan,et al.  Value of targeted prostate biopsy using magnetic resonance-ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigen. , 2014, European urology.

[22]  Hessel Wijkstra,et al.  The role of magnetic resonance imaging (MRI) in focal therapy for prostate cancer: recommendations from a consensus panel , 2014, BJU international.

[23]  Xavier Leroy,et al.  Prostate cancer diagnosis: multiparametric MR-targeted biopsy with cognitive and transrectal US-MR fusion guidance versus systematic biopsy--prospective multicenter study. , 2013, Radiology.

[24]  Thomas Wiegel,et al.  Guidelines on Prostate Cancer , 2013 .

[25]  Fang-Ming Deng,et al.  Prostate cancer: multiparametric MRI for index lesion localization--a multiple-reader study. , 2012, AJR. American journal of roentgenology.

[26]  Baris Turkbey,et al.  Multiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds. , 2011, The Journal of urology.

[27]  J. Chapelon,et al.  Prostate cancer transrectal HIFU ablation: detection of local recurrences using T2-weighted and dynamic contrast-enhanced MRI , 2009, European Radiology.

[28]  Masao Fukunaga,et al.  Prostate cancer: relationships between postbiopsy hemorrhage and tumor detectability at MR diagnosis. , 2008, Radiology.

[29]  A. Villers,et al.  Dynamic contrast enhanced, pelvic phased array magnetic resonance imaging of localized prostate cancer for predicting tumor volume: correlation with radical prostatectomy findings. , 2006, The Journal of urology.

[30]  Murray Turoff,et al.  The Delphi Method: Techniques and Applications , 1976 .